within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DC01_Cefoxitin;

model Cefoxitin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 2.1944444444444445e-06,
    adminDuration = 600,
    adminMass = 2000 / 1000000,
    adminCount = 1,
    Vd = 0.0112,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.0066,
    k12 = 4.833333333333333e-06,
    k21 = 4.833333333333333e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Cefoxitin</td></tr><tr><td>ATC code:</td><td>J01DC01</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>2000</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>11.2</td><td>L</td></tr>
    <tr><td>clearance:</td><td>7.9</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Cefoxitin is a second-generation cephalosporin antibiotic with activity against a broad spectrum of Gram-positive and Gram-negative bacteria, including anaerobes. It is primarily used to treat bacterial infections such as intra-abdominal infections, gynecological infections, and prophylaxis in surgical procedures. Cefoxitin is an approved and widely used drug in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Song, X, &amp; Long, M (2018). Pharmacodynamic model for β-lactam regimens used in surgical prophylaxis: model-based evaluation of standard dosing regimens. <i>International journal of clinical pharmacy</i> 40(5) 1059–1071. DOI:<a href=\"https://doi.org/10.1007/s11096-018-0720-y\">10.1007/s11096-018-0720-y</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30117081/\">https://pubmed.ncbi.nlm.nih.gov/30117081</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.J.J01DC01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Cefoxitin;
